Sotatercept for the treatment of portopulmonary hypertension: a case report
This report demonstrates tolerability and efficacy of Sotatercept in portopulmonary hypertension, identifies candidate biomarkers of treatment response, but also suggests caution may be warranted. Findings from this work support further investigation of Sotatercept in the treatment of portopulmonary hypertension.
Authors
- William J. Zacharias (ORCID: https://orcid.org/0000-0002-2643-0610)
- Arun Jose
- Marina Yasnogorodsky
- Assem Ziady
- Sharlene Fernandes
- Jean Elwing
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Communications Medicine
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1038/s43856-026-01452-6
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00